Radiogenomic Analysis of Chemoresistance in Ovarian Serous Cystadenocarcinoma Using CT-Derived Radiomic Features: Associations with ABCG2 Expression

Federico Greco; Chiara Noemi Greco; Chiara pallara; Antonia Marini; Roberta Montefrancesco; Luca Giordano; Arnaldo Scardapane

doi:10.33218/001c.165246

Loading [Contrib]/a11y/accessibility-menu.js

This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

prnano

Articles
For Authors
Editorial Board
About
Issues
Blog
The Rising Talents List
Journal Policies

search
Facebook (opens in a new tab)
LinkedIn (opens in a new tab)
RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

https://precisionnanomedicine.com/feed

ISSN 2639-9431

Research Article

July 23, 2026 EDT

Radiogenomic Analysis of Chemoresistance in Ovarian Serous Cystadenocarcinoma Using CT-Derived Radiomic Features: Associations with ABCG2 Expression

Federico Greco, M.D., Assistant Professor, Chiara Noemi Greco, M.D., Chiara pallara, M.D., Antonia Marini, M.D., Roberta Montefrancesco, M.D., Luca Giordano, M.D., Arnaldo Scardapane, M.D., Full Professor,

ABCG2Artificial intelligenceChemoresistanceComputed tomographyImaging biomarkersOvarian cancerPrecision medicineRadiogenomicsRadiomicsTumor heterogeneity

ccby-nc-4.0

• https://doi.org/10.33218/001c.165246

prnano

Greco F, Greco CN, pallara C, et al. Radiogenomic Analysis of Chemoresistance in Ovarian Serous Cystadenocarcinoma Using CT-Derived Radiomic Features: Associations with ABCG2 Expression. Precis Nanomed. Published online July 23, 2026:1834-1844. doi:10.33218/001c.165246

Save article as...▾

View more stats